Explore Highlights, Scientists and more!

Explore related topics

2016-a new experimental antibiotic developed by a team of scientists at Rutgers University has been observed to treat deadly methicillin-resistant Staphylococcus aureus (MRSA) infections successfully and restore the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA. In their current study, the researchers show that the combination of their newly developed antibiotic, TXA709, with cefdinir, an antibiotic that has been on the market for almost two decades…

2016-a new experimental antibiotic developed by a team of scientists at Rutgers University has been observed to treat deadly methicillin-resistant Staphylococcus aureus (MRSA) infections successfully and restore the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA. In their current study, the researchers show that the combination of their newly developed antibiotic, TXA709, with cefdinir, an antibiotic that has been on the market for almost two decades…

2016-Addressing physician mishandling of antibiotic testing and prescription is a key focus of new clinical guidelines for antibiotic stewardship issued by the CDC in partnership with the AmericanCollege of Physicians. The guidelines are published in the Annals of Internal Medicine.  The paper includes four pieces of "high-value care advice:"

2016-Addressing physician mishandling of antibiotic testing and prescription is a key focus of new clinical guidelines for antibiotic stewardship issued by the CDC in partnership with the AmericanCollege of Physicians. The guidelines are published in the Annals of Internal Medicine. The paper includes four pieces of "high-value care advice:"

What’s “hapten”-ing in β-lactam hypersensitivity? | Science Translational Medicine

What’s “hapten”-ing in β-lactam hypersensitivity? | Science Translational Medicine

FDA Approves Cubist’s Skin Infection Antibiotic

FDA Approves Cubist’s Skin Infection Antibiotic

Antibiotic Stewardship - The Ultimate Return on Investment

Antibiotic Stewardship–The Ultimate Return on Investment

Antibiotic Stewardship - The Ultimate Return on Investment

Could "Superbug" Infections Kill Millions Per Year? http://www.pharmpro.com/videos/2014/12/could-superbug-infections-kill-millions-year?et_cid=4318027&et_rid=650445760&type=cta

Could "Superbug" Infections Kill Millions Per Year? http://www.pharmpro.com/videos/2014/12/could-superbug-infections-kill-millions-year?et_cid=4318027&et_rid=650445760&type=cta

2016- Researchers have devised an approach for synthesizing new macrolide antibiotics from simple chemical building blocks. Using this method, Andrew Myers of Harvard University and colleagues synthesized more than 300 new antibiotic candidates, several of which were effective against some of the most stubbornly drug-resistant bacterial strains, according to the study published today (May 18) in Nature.

2016- Researchers have devised an approach for synthesizing new macrolide antibiotics from simple chemical building blocks. Using this method, Andrew Myers of Harvard University and colleagues synthesized more than 300 new antibiotic candidates, several of which were effective against some of the most stubbornly drug-resistant bacterial strains, according to the study published today (May 18) in Nature.

Rheumatoid Arthritis Tips Book Review | RA Education | Rheumatoid Arthritis Warrior

Rheumatoid Arthritis Tips Book Review

Rheumatoid Arthritis Tips Book Review | RA Education | Rheumatoid Arthritis Warrior

Pinterest
Search